Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 10, 2026 07:47 ET | Source: Polyrizon Ltd.

Polyrizon Receives Notice of European Patent Publication for Innovative Mucoadhesive Nasal Drug Delivery Technology

Raanana, Israel, June 10, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative...
June 08, 2026 07:00 ET | Source: Marvel Biosciences Corp.

Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204

Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204
June 02, 2026 08:00 ET | Source: Daxor Corporation

Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor

New Technology Expands Daxor’s Diagnostic Capabilities to Enable Continuous, Remote Tracking of Blood Volume Status Using Wearable Sensors, Enhancing Care for Heart Failure, Syncope, Anemia, and...
May 27, 2026 08:00 ET | Source: CDT Equity Inc.

CDT Announces Canadian Patent for AZD5904 in Male Infertility

CDT Announces Canadian Patent for AZD5904 in Male Infertility
May 15, 2026 07:00 ET | Source: Nutriband Inc.

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

AI Products Showcase
April 28, 2026 16:01 ET | Source: PMGC Holdings Inc.

UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions related to GLP-1 Use, Sarcopenia, Muscle Disuse Atrophy, and Certain Neurological Disorders

UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions relate
April 28, 2026 10:17 ET | Source: Block & Leviton LLP

Erasca, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors to Contact the Firm to Possibly Recover Losses

Block & Leviton is investigating Erasca Inc. ($ERAS) for possible securities fraud. Investors who lost money should contact the firm to recover losses.
April 28, 2026 07:30 ET | Source: PMGC Holdings Inc.

NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans

NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans
April 23, 2026 07:30 ET | Source: Marvel Biosciences Corp.

Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit

Marvel Biosciences to participate in 2nd Neuroscience Innovation Partnering & Licensing Summit, allowing Marvel to showcase its progress on global stage
April 22, 2026 07:00 ET | Source: Nutriband Inc.

Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

CEO Gareth Sheridan appears as guest on the Jack Neel Podcast